Announcements Trials
Browse Landscape

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Genitourinary 5Gastrointestinal 4Tumor-Agnostic 3Thoracic 2Other hematologic neoplasm 2Plasma cell 1Myeloid 1Head & Neck 1Classical hematology 1Breast 1

Conditions

Head and Neck Neoplasms 1Chronic Disease 1

Interventions

Cisplatin 631Radiotherapy 339pembrolizumab 329Cetuximab 284Docetaxel 226Radiotherapy, Intensity-Modulated 221Fluorouracil 199Carboplatin 198Paclitaxel 161Nivolumab 145Gemcitabine 125Magnetic Resonance Spectroscopy 99Radiation 91Drug Therapy 86Capecitabine 77toripalimab 75Surveys and Questionnaires 73Surgical Procedures, Operative 72Biopsy 62durvalumab 61Chemoradiotherapy 52Blood Specimen Collection 52Cyclophosphamide 50Specimen Handling 47camrelizumab 46Radiosurgery 46Erlotinib Hydrochloride 46Standard of Care 44130-nm albumin-bound paclitaxel 44tislelizumab 42

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Registries × Head & Neck × Clear all
NCT03546322 2022-07-01

Customized Registry Tool for Tracking Adherence to Clinical Guidelines for Head and Neck Cancers

University of California, San Francisco

Completed
802 enrolled
Head & Neck

Chronic Disease, Head and Neck Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡